Details

NameSymbolSector
MARKSANS PHARMA LTD.MARKSANSPharmaceuticals
Open
337.5
High
349.95
Low
331.6
Close
335.9
Volume
5090238
Exchange
nse
Time
08-Sep-2026

Outlook

Score:  

4.75

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Marksans Pharma is  
High Wave
Estimated Stoploss of Marksans Pharma is ₹  
349.95
Marksans Pharma has a  
Bearishℹ
 pattern. 
Formation of  
High Wave
 candle pattern indicates the trend direction of Marksans Pharma is  
Unpredictableℹ
. 

Trend

Marksans Pharma is in  
Uptrendℹ
. 
Price of Marksans Pharma is  
Upℹ
 by  

16.11

%. 
Target
Buy @ 

258.85

Sell @ 

339

Current @ 

335.9

Volume

The trade volume of Marksans Pharma has been  
Goodℹ
Though the volume trend for Marksans Pharma appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Marksans Pharma is  

Up

 by  

34.58

% 

Valuation

The current market price of Marksans Pharma is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 3239cr and total assets worth ₹ 3239cr, the balance sheet of Marksans Pharma is:  
Balancedℹ
. 
Cashflow
Marksans Pharma has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 92cr

. It is  
Upℹ
 by  

360

%. 

(*Mar 2025)

64.38% i.e. ₹ 206cr earned in operatingℹ
15.31% i.e. ₹ 49cr spent in investingℹ
20.31% i.e. ₹ 65cr spent in financingℹ
0% in otherℹ
Marksans Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 20cr

. It is  
Downℹ
 by  

88.64

%. 

(*Mar 2024)

52.51% i.e. ₹ 230cr earned in operatingℹ
31.96% i.e. ₹ 140cr spent in investingℹ
15.53% i.e. ₹ 68cr spent in financingℹ
0% in otherℹ
Income
The income of Marksans Pharma is  

₹ 741cr

 and  

Profit

 is :  

₹ 99cr

(*Sep 2025)

Marksans Pharma Profit is up by:  

70.69

% and Income is Up by:  

18.56

% 

(*Sep 2025)

The income of Marksans Pharma is  

₹ 625cr

 and  

Profit

 is :  

₹ 58cr

(*Jun 2025)

Marksans Pharma Profit is down by:  

35.56

% and Income is Down by:  

13.67

% 

(*Jun 2025)

The income of Marksans Pharma is  

₹ 724cr

 and  

Profit

 is :  

₹ 90cr

(*Mar 2025)

Marksans Pharma Profit is down by:  

14.29

% and Income is Up by:  

2.12

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.